158 related articles for article (PubMed ID: 8857599)
21. Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain.
Andrée B; Nyberg S; Ito H; Ginovart N; Brunner F; Jaquet F; Halldin C; Farde L
J Clin Psychopharmacol; 1998 Aug; 18(4):317-23. PubMed ID: 9690698
[TBL] [Abstract][Full Text] [Related]
22. A practical synthesis of the serotonin 5-HT2A receptor antagonist MDL 100907, its enantiomer and their 3-phenolic derivatives as precursors for [11C]labeled PET ligands.
Ullrich T; Rice KC
Bioorg Med Chem; 2000 Oct; 8(10):2427-32. PubMed ID: 11058037
[TBL] [Abstract][Full Text] [Related]
23. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone.
Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA
Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361
[TBL] [Abstract][Full Text] [Related]
24. Identification of serotonin 5-HT3 recognition sites in membranes of N1E-115 neuroblastoma cells by radioligand binding.
Hoyer D; Neijt HC
Mol Pharmacol; 1988 Mar; 33(3):303-9. PubMed ID: 3352595
[TBL] [Abstract][Full Text] [Related]
25. pH-dependent modulation of agonist interactions with [3H]-ketanserin-labelled S2 serotonin receptors.
Battaglia G; Shannon M; Borgundvaag B; Titeler M
Life Sci; 1983 Nov; 33(20):2011-6. PubMed ID: 6645787
[TBL] [Abstract][Full Text] [Related]
26. Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors.
Scandroglio A; Monferini E; Borsini F
Pharmacol Res; 2001 Feb; 43(2):179-83. PubMed ID: 11243720
[TBL] [Abstract][Full Text] [Related]
27. [3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.
Bonhaus DW; Loury DN; Jakeman LB; To Z; DeSouza A; Eglen RM; Wong EH
J Pharmacol Exp Ther; 1993 Nov; 267(2):961-70. PubMed ID: 8246171
[TBL] [Abstract][Full Text] [Related]
28. Demonstration of S2-receptor binding sites on cat blood platelets using [3H]ketanserin.
Leysen JE; Gommeren W; De Clerck F
Eur J Pharmacol; 1983 Mar; 88(1):125-30. PubMed ID: 6852103
[TBL] [Abstract][Full Text] [Related]
29. Investigation of the CNS penetration of a potent 5-HT2a receptor antagonist (MDL 100,907) and an active metabolite (MDL 105,725) using in vivo microdialysis sampling in the rat.
Scott DO; Heath TG
J Pharm Biomed Anal; 1998 May; 17(1):17-25. PubMed ID: 9608422
[TBL] [Abstract][Full Text] [Related]
30. Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.
Noda-Saita K; Matsumoto M; Hidaka K; Hatanaka K; Ohmori J; Okada M; Yamaguchi T
Biochem Biophys Res Commun; 1999 Feb; 255(2):367-70. PubMed ID: 10049714
[TBL] [Abstract][Full Text] [Related]
31. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
32. [3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortex.
Alves-Rodrigues A; Leurs R; Wu TS; Prell GD; Foged C; Timmerman H
Br J Pharmacol; 1996 Aug; 118(8):2045-52. PubMed ID: 8864541
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
Khawaja X; Ennis C; Minchin MC
Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
[TBL] [Abstract][Full Text] [Related]
34. Cortical [3H]ketanserin binding and 5-HT2A receptor-mediated inositol phosphate production in the spontaneously hypertensive rat and Lewis rat strains.
Gauffre JC; Aguerre S; Mormède P; Chaouloff F
Neurosci Lett; 1997 Oct; 236(2):112-6. PubMed ID: 9404824
[TBL] [Abstract][Full Text] [Related]
35. Characterization of serotonin binding sites on human platelets.
McBride PA; Mann JJ; McEwen B; Biegon A
Life Sci; 1983 Nov; 33(20):2033-41. PubMed ID: 6645789
[TBL] [Abstract][Full Text] [Related]
36. [3H]ketanserin binds to non-5-HT2 sites in rabbit cerebral cortex and neostriatum.
Dewar KM; Lima L; Reader TA
Neurochem Res; 1990 May; 15(5):507-14. PubMed ID: 2115148
[TBL] [Abstract][Full Text] [Related]
37. Comparative recovery kinetics of 5-hydroxytryptamine 1A, 1B, and 2A receptor subtypes in rat cortex after receptor inactivation: evidence for differences in receptor production and degradation.
Pinto W; Battaglia G
Mol Pharmacol; 1994 Dec; 46(6):1111-9. PubMed ID: 7808431
[TBL] [Abstract][Full Text] [Related]
38. In vitro labeling of serotonin-S2 receptors: synthesis and binding characteristics of [3H]-7-aminoketanserin.
Wouters W; Janssen CG; Van Dun J; Thijssen JB; Laduron PM
J Med Chem; 1986 Sep; 29(9):1663-8. PubMed ID: 3746815
[TBL] [Abstract][Full Text] [Related]
39. [3H]Rauwolscine: an antagonist radioligand for the cloned human 5-hydroxytryptamine2b (5-HT2B) receptor.
Wainscott DB; Sasso DA; Kursar JD; Baez M; Lucaites VL; Nelson DL
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):17-24. PubMed ID: 9459568
[TBL] [Abstract][Full Text] [Related]
40. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
Sumiyoshi T; Ichikawa J; Meltzer HY
Neuropsychopharmacology; 1997 Mar; 16(3):183-90. PubMed ID: 9138434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
